P2X7R antagonists can inhibit tumor growth and metastasis formation, and P2X7R expression or activation increases NFAT and NF-κB activity, intracellular Ca2+ levels and ATP production in addition to activating the c-Myc oncogene. The gene discussed is MYC; the disease is neoplasm.